Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00242853
Status:
COMPLETED
Last Update Posted:
2008-10-13
First Post:
2005-10-19
Brief Title:
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
An Enabling Study to Investigate the Correlation of Biomarkers of the Activity of Inducible Nitric Oxide Synthase iNOS With Disease Activity and Treatment Response in Patients With Rheumatoid ArthritisRA
Status:
COMPLETED
Status Verified Date:
2008-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being conducted to validate various biomarkers in patients with RA with varying levels of disease severity Subjects with a diagnosis of rheumatoid arthritis RA will be included as controls The sudy will measure the baseline levels and the intra- and inter-subject variability of exhaled nitric oxide NO in patients with inactivemild and moderatesevere RA on stable therapy or during a course glucocorticoids In addition exhaled NO levels will be correlated with intra-articular inflammation power Doppler ultrasonography as well as markers of systemic inflammation CRP ESR
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None